ATLASATLAS fair value
₩6,951
Above fair value · 40% premium
Range: ₩6,256–₩7,647Fair valuePrice
Reyon Pharmaceutical (102460.KO)
Reyon Pharmaceutical stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Korea Exchange (KOSPI) · South Korea
₩9,720▼ -0.10%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
53%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Reyon Pharmaceutical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Reyon Pharmaceutical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Reyon Pharmaceutical's fair value at about ₩6,951 per share (reasonable range: ₩6,256 to ₩7,647). At ₩9,720, the stock trades 40% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Reyon Pharmaceutical a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩9,387 and ₩10,140; in 9 out of 10, between ₩8,766 and ₩10,859. Estimated annual volatility is 15%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩180B
- Market cap (USD)
- $135M
- 52-week high
- ₩13,200
- 52-week low
- ₩9,100
- Revenue (12 months)
- ₩143B
- Gross margin
- 25.4%
- Operating margin
- -19.6%
- Net margin
- -23.9%
- Beta
- 0.48
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Reyon Pharmaceutical sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 102460.KO has traded between ₩9,100 and ₩13,200. Today it is 26.4% below that high and 7% above its low.
Its beta is 0.48: it tends to move less than the market.
About the company
REYON Pharmaceutical Co., Ltd. manufactures and sells medicines.
Want to see everything about Reyon Pharmaceutical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Reyon Pharmaceutical (102460.KO) fair value?
About ₩6,951 per share according to ATLAS (reasonable range: ₩6,256 to ₩7,647). With the stock at ₩9,720, it is 40% above it.
What is the chance 102460.KO goes up next month?
53%: close to a coin flip. In half of the simulated outcomes, 102460.KO ends the month between ₩9,387 and ₩10,140.
How big is Reyon Pharmaceutical and what is its P/E ratio?
Reyon Pharmaceutical's market capitalization is ₩180B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is 102460.KO?
ATLAS estimates annual volatility at 15%. In a typical month, half of the outcomes end between ₩9,387 and ₩10,140.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer